News

but older adults now have a new weapon against the virus. Moderna said it has received approval from the U.S. Food and Drug Administration (FDA) for its latest COVID-19 vaccine, mNEXSPIKE.
The agency recommends manufacturers update their vaccines to target the JN.1 strain. At the same time, HHS head Robert F.
Previously, the FDA recommended COVID-19 vaccines for everyone aged 6 months and older. Under the new plan, shots for healthy ...
The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory processes.
The agency will encourage new clinical trials on Covid-19 vaccines before approving them for children and healthy adults.